An all-encompassing approach

Sanofi performed solidly in 2011 with sales growth of 12%.
Lantus® is the Group’s number one product, with sales of €3,916 million (+15%) in 2011.
In emerging markets, sales for Sanofi’s diabetes products progressed 20.1%.

Sanofi offers a comprehensive approach to diabetes management, from diagnosis to patient services. The 2011 launches of BGStar® and iBGStarTM in several European markets illustrate the company’s unique position focused on patients’ needs.

Read more